[Antitumor cellular immunotherapy: the breakthrough of dendritic cells].
Angevin
E
E
Unité d'immunologie, département de biologie clinique, Institut Gustave-Roussy, Villejuif.
André
F
F
Zitvogel
L
L
D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology / Q000502:physiology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods* / Q000639:trends; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D000951:Antigens, Neoplasm; D000949:Histocompatibility Antigens Class II